Rectal Indomethacin to Prevent Post-ERCP Pancreatitis (Indomethacin)
Routine Rectal Indomethacin Given Before Procedure Reduced Overall Pancreatitis in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP): A Multi-center, Single-blinded, Randomized Controlled Trial
Sponsor: Air Force Military Medical University, China
This NA trial investigates Post-ERCP Acute Pancreatitis and is currently completed. Air Force Military Medical University, China leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Nov 2020 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Dec 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Air Force Military Medical University, China
For direct contact, visit the study record on ClinicalTrials.gov .